NUTRACEUTIX INC
S-8, EX-24.3, 2000-06-28
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NUTRACEUTIX INC, S-8, EX-24.2, 2000-06-28
Next: NUTRACEUTIX INC, S-8, EX-24.4, 2000-06-28



<PAGE>   1
                                                                    Exhibit 24.3

                      POWER OF ATTORNEY OF CARL W. SCHAFER


      KNOW ALL MEN BY THESE PRESENTS, that the undersigned, Carl W. Schafer
constitutes and appoints David T. Howard or Steven H. Moger his true and lawful
attorney-in-fact and agent, for him and his name, place and stead, in any and
all capacities, to execute the Registration Statement on Form S-8, registering
1,000,000 shares of common stock of Nutraceutix, Inc., a Delaware corporation,
issuable upon exercise of options granted pursuant to the Nutraceutix, Inc. 1995
Amended Stock Option Plan, and any amendments (including post-effective
amendments) or supplements thereto, and to file this Power of Attorney and the
Form S-8, with all exhibits thereto, and other documents in connection therewith
with the Securities and Exchange Commission and any stock exchange or similar
authority, granting unto said attorney-in-fact and agent full power and
authority to do and perform each and every act and thing requisite or necessary
to be done in and about the premises, as fully to all intents and purposes as he
might or could do in person, hereby ratifying and confirming all that said
attorney-in-fact and agent may do or cause to be done by virtue hereof.

      This Power of Attorney shall remain in full force and effect until revoked
by the undersigned in a signed writing delivered to the foregoing
attorney-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed this 22nd day of June, 2000.


                                            /s/  Carl W. Schafer
                                            ------------------------------------
                                            CARL W. SCHAFER





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission